logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Tarek Meniawy

Fiona Stanley Fremantle Hospitals Group
H指数:34
被引数:4,760

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase I study of the OX40 agonist BGB-A445 with or without tislelizumab, an anti–PD-1 monoclonal antibody, in patients with advanced solid tumors: dose-escalation results

一项关于OX40激动剂BGB-A445与或不与tislelizumab（一种抗PD-1单克隆抗体）联合治疗晚期实体瘤患者的I期研究：剂量递增结果

Cancer Chemotherapy and Pharmacology
IF2.3
2025-10-080
OA
Jayesh Desai; Sanjeev Deva; Bo Gao; Kunyu Yang; Kenneth J. O’Byrne; Meili Sun; Tianshu Liu; Tarek Meniawy; Xinmin Yu; Mark Voskoboynik; Diwakar Davar; Marco Matos; Shiangjiin Leaw; Tahmina Rahman; Xiaofei Qu; Hugh Giovinazzo; Xin Chen; Yan Dong; Daphne Day
Adjuvant nivolumab v placebo in stage IIB/C melanoma: 3-year results from CheckMate 76K

辅助治疗中使用尼洛姆单抗与安慰剂对比治疗stage IIB/C黑色素瘤：CheckMate 76K研究3年结果

ANNALS OF ONCOLOGY
IF65.4
2024-09-014
PRE
Long, G. V.; Del Vecchio, M.; Hoeller, C.; Weber, J. S.; Grob, J. J.; Mohr, P.; Grabbe, S.; Dutriaux, C.; Sileni, V. Chiarion; Mackiewicz, J.; Rutkowski, P.; Arenberger, P.; Quereux, G.; Meniawy, T.; Ascierto, P. A.; Taube, J.; Nassar, A.; Wang, W.; Kirkwood, J. M.
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab
NPJ PRECISION ONCOLOGY
IF8
2024-07-190
OA
Gogas, Helen; Ravimohan, Shruthi; Datta, Antara; Chhibber, Aparna; Couselo, Eva Munoz; Diab, Adi; Pereira, Caio; Quereux, Gaelle; Sandhu, Shahneen; Curti, Brendan; Khushalani, Nikhil I.; Taylor, Matthew H.; Daniels, Gregory A.; Spreafico, Anna; Meniawy, Tarek; Van Den Eertwegh, Alfons J. M.; Sun, Yongliang; Arriaga, Yull; Zhou, Ming; Long, Georgina V.; Lebbe, Celeste
Plain language summary of the CheckMate 76K study results: nivolumab given after stage 2B/2C melanoma is removed by surgery
FUTURE ONCOLOGY
IF2.6
2024-02-231
OA
Kirkwood, John M.; Del Vecchio, Michele; Weber, Jeffrey; Hoeller, Christoph; Grob, Jean-Jacques; Mohr, Peter; Loquai, Carmen; Dutriaux, Caroline; Chiarion-Sileni, Vanna; Mackiewicz, Jacek; Rutkowski, Piotr; Arenberger, Petr; Quereux, Gaelle; Meniawy, Tarek M.; Ascierto, Paolo A.; Menzies, Alexander M.; Durani, Piyush; Lobo, Maurice; Campigotto, Federico; Gastman, Brian; Long, Georgina, V
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study

个体化新抗原治疗mRNA-4157 (V940) 联合pembrolizumab与pembrolizumab单药治疗黑色素瘤 (KEYNOTE-942): 一项随机2b期研究

LANCET
IF88.5
2024-02-01121
PRE
Weber, Jeffrey S.; Carlino, Matteo S.; Khattak, Adnan; Meniawy, Tarek; Ansstas, George; Taylor, Matthew H.; Kim, Kevin B.; McKean, Meredith; Long, Georgina, V; Sullivan, Ryan J.; Faries, Mark; Tran, Thuy T.; Cowey, C. Lance; Pecora, Andrew; Shaheen, Montaser; Segar, Jennifer; Medina, Theresa; Atkinson, Victoria; Gibney, Geoffrey T.; Luke, Jason J.; Thomas, Sajeve; Buchbinder, Elizabeth, I; Healy, Jane A.; Huang, Mo; Morrissey, Manju; Feldman, Igor; Sehgal, Vasudha; Robert-Tissot, Celine; Hou, Peijie; Zhu, Lili; Brown, Michelle; Aanur, Praveen; Meehan, Robert S.; Zaks, Tal
Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial (vol 29, pg 2835, 2023)
NATURE MEDICINE
IF50
2024-01-040
OAAI
Kirkwood, John M.; Del Vecchio, Michele; Weber, Jeffrey; Hoeller, Christoph; Grob, Jean-Jacques; Mohr, Peter; Loquai, Carmen; Dutriaux, Caroline; Chiarion-Sileni, Vanna; Mackiewicz, Jacek; Rutkowski, Piotr; Arenberger, Petr; Quereux, Gaelle; Meniawy, Tarek M.; Ascierto, Paolo A.; Menzies, Alexander M.; Durani, Piyush; Lobo, Maurice; Campigotto, Federico; Gastman, Brian; Long, Georgina V.
Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial (16 OCT, 10.1038/s41591-023-02583-2, 2023 )

nivolumab在切除的IIB/C期黑色素瘤中的辅助治疗: 随机，3期CheckMate 76k试验的主要结果 (10.1038 10月16日/s41591-023-02583-2，2023)

NATURE MEDICINE
IF50
2023-11-030
OAAI
Kirkwood, John M.; Del Vecchio, Michele; Weber, Jeffrey; Hoeller, Christoph; Grob, Jean-Jacques; Mohr, Peter; Loquai, Carmen; Dutriaux, Caroline; Chiarion-Sileni, Vanna; Mackiewicz, Jacek; Rutkowski, Piotr; Arenberger, Petr; Quereux, Gaelle; Meniawy, Tarek M.; Ascierto, Paolo A.; Menzies, Alexander M.; Durani, Piyush; Lobo, Maurice; Campigotto, Federico; Gastman, Brian; Long, Georgina V.
Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial

nivolumab在切除的IIB/C期黑色素瘤中的辅助治疗: 随机，3期CheckMate 76k试验的主要结果

NATURE MEDICINE
IF50
2023-10-1653
OAAI
Kirkwood, John; Del Vecchio, Michele; Weber, Jeffrey; Hoeller, Christoph; Grob, Jean-Jacques; Mohr, Peter; Loquai, Carmen; Dutriaux, Caroline; Chiarion-Sileni, Vanna; Mackiewicz, Jacek; Rutkowski, Piotr; Arenberger, Petr; Quereux, Gaelle; Meniawy, Tarek M.; Ascierto, Paolo A.; Menzies, Alexander M.; Durani, Piyush; Lobo, Maurice; Campigotto, Federico; Gastman, Brian; Long, Georgina V.
mRNA-4157 (V940) individualized neoantigen therapy plus pembrolizumab vs pembrolizumab in high-risk resected melanoma: Clinical efficacy and correlates of response

mRNA-4157 (V940) 个体化新抗原治疗联合帕博利珠单抗与帕博利珠单抗治疗高危黑色素瘤: 临床疗效和反应相关性

ANNALS OF ONCOLOGY
IF65.4
2023-10-011
OA
Weber, J. S.; Khattak, A.; Carlino, M.; Sullivan, R. J.; Luke, J. J.; Meniawy, T.; Taylor, M.; Ansstas, G.; Kim, K.; Mckean, M.; Faries, M.; Tran, T.; Cowey, C. L.; Pecora, A.; Medina, T.; Atkinson, V. G.; Gibney, G.; Buchbinder, E.; Meehan, R.; Long, G. V.
Targeting homologous recombination deficiency in uterine leiomyosarcoma

靶向子宫平滑肌肉瘤的同源重组缺陷

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
IF12.8
2023-05-0410
OAAI
Dall, Genevieve; Vandenberg, Cassandra J. J.; Nesic, Ksenija; Ratnayake, Gayanie; Zhu, Wenying; Vissers, Joseph H. A.; Bedo, Justin; Penington, Jocelyn; Wakefield, Matthew J. J.; Kee, Damien; Carmagnac, Amandine; Lim, Ratana; Shield-Artin, Kristy; Milesi, Briony; Lobley, Amanda; Kyran, Elizabeth L. L.; O'Grady, Emily; Tram, Joshua; Zhou, Warren; Nugawela, Devindee; Stewart, Kym Pham; Caldwell, Reece; Papadopoulos, Lia; Ng, Ashley P. P.; Dobrovic, Alexander; Fox, Stephen B. B.; McNally, Orla; Power, Jeremy D. D.; Meniawy, Tarek; Tan, Teng Han; Collins, Ian M. M.; Klein, Oliver; Barnett, Stephen; Olesen, Inger; Hamilton, Anne; Hofmann, Oliver; Grimmond, Sean; Papenfuss, Anthony T. T.; Scott, Clare L. L.; Barker, Holly E. E.
Preliminary dose escalation results of ERAS-601 in combination with cetuximab in FLAGSHP-1: a phase I study of ERAS-601, a potent and selective SHP2 inhibitor, in patients with previously treated advanced or metastatic solid tumors
CANCER RESEARCH
IF16.6
2023-04-141
PRE
McKean, Meredith; Rosen, Ezra; Barve, Minal; Meniawy, Tarek; Wang, Judy; Hong, David S.; Yang, Jennifer; Li, Zhengrong; Picard, Roxana; Brail, Les; Vecchio, Daniela; John, Thomas; Cohen, Ezra; Obara, Gregory; Parikh, Aparna
Joint modeling of safety and peripheral mode-of-action (MoA) biomarkers to support RP2D identification in Phase 1 study of SAR444245 (SAR'245) as monotherapy (mono) or combined with pembrolizumab (pembro) in patients with advanced solid tumors
CANCER RESEARCH
IF16.6
2023-04-040
PRE
Fu, Siqing; Falchook, Gerald S.; Barve, Minal; McKean, Meredith; Tan, Tira J.; Lemech, Charlotte; Chee, Cheng E.; Marina, Neyssa; Abbadessa, Giovanni; Meng, Robin; Rotolo, Federico; Wang, Hong; Deng, Jason; Wang, Wenting; Wang, Rui; Meniawy, Tarek

研究方向

暂未获取到该数据
E
Elin S. Gray
H 指数:51论文数:223被引数:8,187
G
Georgina V. Long
H 指数:169论文数:1,834被引数:17.3万
M
Michael Millward
H 指数:61论文数:456被引数:1.6万
L
Leslie Calapre
H 指数:20论文数:56被引数:1,282
J
Jeffrey S. Weber
H 指数:122论文数:1,158被引数:9.8万
L
Lydia Warburton
H 指数:14论文数:57被引数:761
G
G. Quéreux
H 指数:37论文数:386被引数:5,146
L
Linda Mileshkin
H 指数:72论文数:563被引数:3.2万
A
Alexander M. Menzies
H 指数:85论文数:760被引数:3.1万
P
Peter Mohr
H 指数:46论文数:247被引数:2.0万